Aneuploidy as a mechanism for stress-induced liver adaptation.

Over half of the mature hepatocytes in mice and humans are aneuploid and yet retain full ability to undergo mitosis. This observation has raised the question of whether this unusual somatic genetic variation evolved as an adaptive mechanism in response to hepatic injury. According to this model, hepatotoxic insults select for hepatocytes with specific numerical chromosome abnormalities, rendering them differentially resistant to injury. To test this hypothesis, we utilized a strain of mice heterozygous for a mutation in the homogentisic acid dioxygenase (Hgd) gene located on chromosome 16. Loss of the remaining Hgd allele protects from fumarylacetoacetate hydrolase (Fah) deficiency, a genetic liver disease model. When adult mice heterozygous for Hgd and lacking Fah were exposed to chronic liver damage, injury-resistant nodules consisting of Hgd-null hepatocytes rapidly emerged. To determine whether aneuploidy played a role in this phenomenon, array comparative genomic hybridization (aCGH) and metaphase karyotyping were performed. Strikingly, loss of chromosome 16 was dramatically enriched in all mice that became completely resistant to tyrosinemia-induced hepatic injury. The frequency of chromosome 16-specific aneuploidy was approximately 50%. This result indicates that selection of a specific aneuploid karyotype can result in the adaptation of hepatocytes to chronic liver injury. The extent to which aneuploidy promotes hepatic adaptation in humans remains under investigation.

[1]  M. Forest,et al.  aku, a mutation of the mouse homologous to human alkaptonuria, maps to chromosome 16. , 1994, Genomics.

[2]  C. Bréchot,et al.  Liver cell polyploidization: A pivotal role for binuclear hepatocytes , 2003 .

[3]  V. Paradis,et al.  Clonal Analysis of Micronodules in Virus C-Induced Liver Cirrhosis Using Laser Capture Microdissection (LCM) and HUMARA Assay , 2000, Laboratory Investigation.

[4]  Yim Ap.  Some flow-cytofluorimetric studies of the nuclear ploidy of mouse hepatocytes: iii. further observations on early changes in nuclear ploidy of mouse hepatocytes following various experimental procedures. , 1982 .

[5]  Philippe Soriano,et al.  Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. , 1993, Genes & development.

[6]  Anita Saraf,et al.  Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast , 2010, Nature.

[7]  M. Grompe,et al.  In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  David Pellman,et al.  A Mechanism Linking Extra Centrosomes to Chromosomal Instability , 2009, Nature.

[9]  Stylianos E. Antonarakis,et al.  Chromosome 21 and Down syndrome: from genomics to pathophysiology , 2004, Nature Reviews Genetics.

[10]  G. Sakuta,et al.  Human hepatocyte polyploidization kinetics in the course of life cycle , 1993, Virchows Archiv. B, Cell pathology including molecular pathology.

[11]  S. Strom,et al.  Frequent aneuploidy among normal human hepatocytes. , 2012, Gastroenterology.

[12]  V. Paradis,et al.  Clonal analysis of macronodules in cirrhosis , 1998, Hepatology.

[13]  Norman Pavelka,et al.  Aneuploidy Underlies Rapid Adaptive Evolution of Yeast Cells Deprived of a Conserved Cytokinesis Motor , 2008, Cell.

[14]  M. Grompe,et al.  Ploidy Reductions in Murine Fusion-Derived Hepatocytes , 2009, PLoS genetics.

[15]  H. Yamagishi,et al.  Clonal expansion in evolution of chronic hepatitis to hepatocellular carcinoma as seen at an X‐chromosome locus , 2000, Hepatology.

[16]  M. Grompe,et al.  The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion. , 1999, The American journal of pathology.

[17]  M. Grompe,et al.  Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. , 1997, The American journal of pathology.

[18]  [Progressive polyploidy in mouse liver following repeated hepatectomy]. , 1975, Tsitologiia.

[19]  L. Stubbs,et al.  Zooming in on the human-mouse comparative map: genome conservation re-examined on a high-resolution scale. , 1997, Genome research.

[20]  C. Disteche,et al.  Ring X and other structural X chromosome abnormalities: X inactivation and phenotype. , 2001, Seminars in reproductive medicine.

[21]  R. Tanguay,et al.  The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion. , 1997, Biochemical and biophysical research communications.

[22]  M. Grompe,et al.  Identification of the mutation in the alkaptonuria mouse model , 1999, Human mutation.

[23]  D. Xie,et al.  Down‐regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma , 2010, Hepatology.

[24]  Philippe Soriano,et al.  Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. , 1991, Genes & development.

[25]  David Pellman,et al.  Causes and consequences of aneuploidy in cancer , 2012, Nature Reviews Genetics.

[26]  M. Grompe,et al.  Cell fusion is the principal source of bone-marrow-derived hepatocytes , 2003, Nature.

[27]  S. Celton-Morizur,et al.  Liver tetraploidization is controlled by a new process of incomplete cytokinesis , 2007, Journal of Cell Science.

[28]  S. Lindstedt,et al.  On the enzymic defects in hereditary tyrosinemia. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Grompe,et al.  Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I , 1996, Nature Genetics.

[30]  L. D. White,et al.  Bacterial artificial chromosome-emulation oligonucleotide arrays for targeted clinical array-comparative genomic hybridization analyses , 2008, Genetics in Medicine.

[31]  J. Miyazaki,et al.  Complete Rescue of Lethal Albino c 14CoS Mice by Null Mutation of 4-Hydroxyphenylpyruvate Dioxygenase and Induction of Apoptosis of Hepatocytes in These Mice by in VivoRetrieval of the Tyrosine Catabolic Pathway* , 1997, The Journal of Biological Chemistry.

[32]  L. Adams,et al.  Non-alcoholic fatty liver disease , 2011, Critical reviews in clinical laboratory sciences.

[33]  R. Fontana,et al.  Mechanisms of drug-induced liver injury: from bedside to bench , 2011, Nature Reviews Gastroenterology &Hepatology.

[34]  M. Grompe,et al.  The ploidy-conveyor of mature hepatocytes as a source of genetic variation , 2010, Nature.

[35]  G. Tseng,et al.  Gene deletions and amplifications in human hepatocellular carcinomas: correlation with hepatocyte growth regulation. , 2012, The American journal of pathology.

[36]  E. Sandgren,et al.  Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes. , 2000, The American journal of pathology.

[37]  M. Grompe,et al.  Erratum: Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I , 1996, Nature Genetics.

[38]  Tae-Min Kim,et al.  Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q , 2008, International journal of cancer.

[39]  M. Kay,et al.  Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I. , 1997, Human gene therapy.